Log in
NASDAQ:AVRO

AVROBIO News Headlines

$13.39
-0.11 (-0.81 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.27
Now: $13.39▼
$13.67
50-Day Range
$13.50
MA: $15.24▼
$17.10
52-Week Range
$9.76
Now: $13.39▼
$29.32
Volume298,728 shs
Average Volume295,647 shs
Market Capitalization$488.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

Headlines

AVROBIO (NASDAQ AVRO) News Headlines Today

Source:
SourceHeadline
AVROBIO (NASDAQ:AVRO) Rating Increased to Hold at Zacks Investment ResearchAVROBIO (NASDAQ:AVRO) Rating Increased to Hold at Zacks Investment Research
marketbeat.com - November 18 at 5:15 PM
AVROBIO (NASDAQ:AVRO) Downgraded by BidaskClub to "Sell"AVROBIO (NASDAQ:AVRO) Downgraded by BidaskClub to "Sell"
marketbeat.com - October 31 at 11:31 AM
Avrobio (NASDAQ:AVRO) Downgraded to Sell at BidaskClubAvrobio (NASDAQ:AVRO) Downgraded to Sell at BidaskClub
marketbeat.com - September 26 at 2:07 AM
Avrobio (NASDAQ:AVRO) Downgraded by Zacks Investment Research to HoldAvrobio (NASDAQ:AVRO) Downgraded by Zacks Investment Research to Hold
marketbeat.com - August 11 at 5:34 PM
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors - StreetInsider.comPandion Therapeutics Appoints Katina Dorton to its Board of Directors - StreetInsider.com
streetinsider.com - December 3 at 4:08 PM
Critical Analysis: Autolus Therapeutics (NASDAQ:AUTL) and AVROBIO (NASDAQ:AVRO)Critical Analysis: Autolus Therapeutics (NASDAQ:AUTL) and AVROBIO (NASDAQ:AVRO)
americanbankingnews.com - December 1 at 5:08 AM
AVROBIO Announces Closing of Underwritten Public Offering - Yahoo FinanceAVROBIO Announces Closing of Underwritten Public Offering - Yahoo Finance
finance.yahoo.com - November 24 at 5:59 PM
Avrobio prices equity offering at $15Avrobio prices equity offering at $15
seekingalpha.com - November 21 at 2:03 PM
Titan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers; AVROBIO, Stealth BioTherapeutics among losers - Seeking AlphaTitan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers; AVROBIO, Stealth BioTherapeutics among losers - Seeking Alpha
seekingalpha.com - November 20 at 2:07 PM
AVROBIO (NASDAQ:AVRO) Shares Gap Down to $16.98AVROBIO (NASDAQ:AVRO) Shares Gap Down to $16.98
americanbankingnews.com - November 20 at 12:04 PM
Form 424B5 AVROBIO, Inc. - StreetInsider.comForm 424B5 AVROBIO, Inc. - StreetInsider.com
streetinsider.com - November 20 at 9:07 AM
AVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh - StreetInsider.comAVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh - StreetInsider.com
streetinsider.com - November 20 at 9:07 AM
AVROBIO readies $75M equity offering - Seeking AlphaAVROBIO readies $75M equity offering - Seeking Alpha
seekingalpha.com - November 19 at 7:20 PM
An ETF to Solve the Low Interest Rate Riddle - NasdaqAn ETF to Solve the Low Interest Rate Riddle - Nasdaq
nasdaq.com - November 19 at 2:20 PM
Mizuho Reiterates Buy Rating for AVROBIO (NASDAQ:AVRO)Mizuho Reiterates Buy Rating for AVROBIO (NASDAQ:AVRO)
americanbankingnews.com - November 18 at 9:38 AM
AVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipeline - Yahoo FinanceAVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipeline - Yahoo Finance
finance.yahoo.com - November 17 at 3:19 PM
Avrobio reports new data across clinical programs in lysosomal disorderAvrobio reports new data across clinical programs in lysosomal disorder
seekingalpha.com - November 17 at 9:55 AM
AVROBIO (NASDAQ:AVRO) Earns Buy Rating from Analysts at Berenberg BankAVROBIO (NASDAQ:AVRO) Earns Buy Rating from Analysts at Berenberg Bank
americanbankingnews.com - November 11 at 12:28 PM
AVROBIO (NASDAQ:AVRO) Posts Earnings Results, Misses Estimates By $0.20 EPSAVROBIO (NASDAQ:AVRO) Posts Earnings Results, Misses Estimates By $0.20 EPS
americanbankingnews.com - November 10 at 1:35 PM
AVROBIO (NASDAQ:AVRO) Shares Up 10.6%AVROBIO (NASDAQ:AVRO) Shares Up 10.6%
americanbankingnews.com - November 9 at 11:45 PM
Heres Why Were Not Too Worried About AVROBIOs (NASDAQ:AVRO) Cash Burn Situation - Yahoo FinanceHere's Why We're Not Too Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Situation - Yahoo Finance
finance.yahoo.com - November 6 at 3:24 PM
AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update - Business WireAVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update - Business Wire
businesswire.com - November 5 at 12:29 PM
Whats in the Offing for Hanesbrands (HBI) Q3 Earnings? - NasdaqWhat's in the Offing for Hanesbrands' (HBI) Q3 Earnings? - Nasdaq
nasdaq.com - November 2 at 1:19 PM
AVROBIO Receives Orphan Drug Designation from the European Commission for AVR‑RD‑01, an Investigational Gene Therapy for Fabry DiseaseAVROBIO Receives Orphan Drug Designation from the European Commission for AVR‑RD‑01, an Investigational Gene Therapy for Fabry Disease
finance.yahoo.com - October 29 at 8:43 AM
AVROBIO to Share Clinical and Pipeline Updates at Virtual R&D Day - Business WireAVROBIO to Share Clinical and Pipeline Updates at Virtual R&D Day - Business Wire
businesswire.com - October 26 at 1:17 PM
AVROBIO to Share Clinical and Pipeline Updates at Virtual R&D DayAVROBIO to Share Clinical and Pipeline Updates at Virtual R&D Day
finance.yahoo.com - October 26 at 8:17 AM
Form 8-K AVROBIO, Inc. For: Oct 19 - StreetInsider.comForm 8-K AVROBIO, Inc. For: Oct 19 - StreetInsider.com
streetinsider.com - October 21 at 12:41 PM
AVROBIO Appoints Dr. Gail Farfel to its Board of DirectorsAVROBIO Appoints Dr. Gail Farfel to its Board of Directors
finance.yahoo.com - October 21 at 12:41 PM
AVROBIOs Gaucher Disease Candidate Gets Orphan Drug StatusAVROBIO's Gaucher Disease Candidate Gets Orphan Drug Status
nasdaq.com - October 1 at 7:12 PM
AVROBIOs Gaucher Disease Candidate Gets Orphan Drug Status - Yahoo FinanceAVROBIO's Gaucher Disease Candidate Gets Orphan Drug Status - Yahoo Finance
finance.yahoo.com - September 29 at 1:59 PM
AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease - Business WireAVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease - Business Wire
businesswire.com - September 28 at 8:43 AM
AVROBIO to Present at Two Upcoming Investor Conferences - Business WireAVROBIO to Present at Two Upcoming Investor Conferences - Business Wire
businesswire.com - September 25 at 7:50 AM
AVROBIO (AVRO) Presents At 18th Annual Global Healthcare Virtual Conference - SlideshowAVROBIO (AVRO) Presents At 18th Annual Global Healthcare Virtual Conference - Slideshow
seekingalpha.com - September 14 at 5:52 PM
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business WireAVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
businesswire.com - September 4 at 7:20 AM
AVROBIO to Present at Three Upcoming Investor Conferences - Yahoo FinanceAVROBIO to Present at Three Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - September 3 at 10:18 AM
AVROBIO to Present at Three Upcoming Investor ConferencesAVROBIO to Present at Three Upcoming Investor Conferences
finance.yahoo.com - September 3 at 10:18 AM
AVROBIO (AVRO) Presents At 2020 Wedbush PacGrow Healthcare Conference - SlideshowAVROBIO (AVRO) Presents At 2020 Wedbush PacGrow Healthcare Conference - Slideshow
seekingalpha.com - August 15 at 1:10 AM
Did Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ?Did Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ?
finance.yahoo.com - August 12 at 2:52 PM
Did Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ? - Yahoo FinanceDid Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ? - Yahoo Finance
finance.yahoo.com - August 12 at 9:52 AM
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business WireAVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
businesswire.com - August 7 at 10:00 AM
5 Biotech Stocks Set to Outpace Q2 Earnings Estimates - Yahoo Finance5 Biotech Stocks Set to Outpace Q2 Earnings Estimates - Yahoo Finance
finance.yahoo.com - August 6 at 1:56 PM
AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update - Business WireAVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update - Business Wire
businesswire.com - August 6 at 1:56 PM
AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business UpdateAVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 1:56 PM
Magenta Therapeutics Reports Recent Business Highlights and Second Quarter Financial Results - Business WireMagenta Therapeutics Reports Recent Business Highlights and Second Quarter Financial Results - Business Wire
businesswire.com - August 6 at 8:55 AM
AVROBIO to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference - Yahoo FinanceAVROBIO to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference - Yahoo Finance
finance.yahoo.com - August 5 at 12:53 PM
AVROBIO Sees Hammer Chart Pattern: Time to Buy? - Yahoo FinanceAVROBIO Sees Hammer Chart Pattern: Time to Buy? - Yahoo Finance
finance.yahoo.com - July 27 at 1:59 PM
AVROBIO Sees Hammer Chart Pattern: Time to Buy?AVROBIO Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - July 27 at 1:59 PM
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceAVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - July 9 at 7:43 AM
BRIEF-Avrobio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - ReutersBRIEF-Avrobio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Reuters
www.reuters.com - July 8 at 10:08 AM
BRIEF-Avrobio Announces New Patients Dosed In Gaucher Disease And Cystinosis Clinical Trials - ReutersBRIEF-Avrobio Announces New Patients Dosed In Gaucher Disease And Cystinosis Clinical Trials - Reuters
www.reuters.com - July 6 at 12:06 PM
AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials - Business WireAVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials - Business Wire
www.businesswire.com - July 6 at 7:06 AM
AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical TrialsAVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials
finance.yahoo.com - July 6 at 7:06 AM
Notable Two Hundred Day Moving Average Cross - AVRO - NasdaqNotable Two Hundred Day Moving Average Cross - AVRO - Nasdaq
www.nasdaq.com - June 29 at 7:37 PM
AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer - Business WireAVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer - Business Wire
www.businesswire.com - June 29 at 9:34 AM
This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.